Home Medicines Diampa LXR 5mg+2.5mg+1000mg Tablet – Triple Combination Empagliflozin, Linagliptin & Metformin XR
Diampa LT 25mg+5mg Tablet – High-Strength Empagliflozin 25mg & Linagliptin Back to Medicines Diampa M 12.5/850mg Tablet – Empagliflozin 12.5mg + Metformin 850mg for Powerful Type 2 Diabetes
Diampa LXR 5mg+2.5mg+1000mg Tablet

Diampa LXR 5mg+2.5mg+1000mg Tablet – Triple Combination Empagliflozin, Linagliptin & Metformin XR

  • Empagliflozin 5mg + Linagliptin 2.5mg + Metformin XR 1000mg triple therapy
  • Once-daily tablet with heart, kidney & weight benefits
In stock
9 People are viewing this right now
Sale price Rs.224.00 PKR
Add to Wishlist

Diampa LXR 5mg+2.5mg+1000mg Tablet
Diampa LXR 5mg+2.5mg+1000mg Tablet – Triple Combination Empagliflozin, Linagliptin & Metformin XR
Sale priceRs.224.00 PKR
SKU:
Categories: Medicines Tablets & Capsules
Tags: Combination Tablet Diabetes Triple Therapy SGLT2 + DPP4 + Metformin
Diampa LXR 5mg+2.5mg+1000mg Tablet

Diampa LXR 5mg+2.5mg+1000mg Tablet – Triple Combination Empagliflozin, Linagliptin & Metformin XR

Rs.224.00

Diampa LXR 5mg+2.5mg+1000mg Tablet – Complete Triple Therapy in One Extended-Release Tablet

Diampa LXR 5mg+2.5mg+1000mg Tablet is an advanced fixed-dose combination of Empagliflozin 5mg (SGLT2 inhibitor), Linagliptin 2.5mg (DPP-4 inhibitor), and Metformin XR 1000mg that delivers powerful, synergistic blood sugar control through three different mechanisms in a single once-daily dose. Ideal as initial triple therapy or when dual therapy is insufficient, it significantly lowers HbA1c, offers proven cardiovascular and kidney protection from the Empagliflozin component, and improves adherence with its convenient extended-release formulation.

  • Triple mechanism for excellent HbA1c reduction in one tablet
  • Proven cardio-renal protection from Empagliflozin component
  • Extended-release metformin improves GI tolerance
  • Supports modest weight loss and low hypoglycemia risk
  • Once-daily dosing enhances patient compliance

  1. Take one Diampa LXR 5mg+2.5mg+1000mg tablet once daily with a meal (preferably evening) to reduce GI side effects
  2. Swallow the tablet whole with water – never crush, chew, or break (extended-release)
  3. Follow your doctor-recommended diet and exercise plan
  4. Regularly monitor blood glucose levels at home
  5. Attend scheduled check-ups for kidney function, vitamin B12, and diabetes control

Q1: Is this suitable as a starting triple therapy?
A1: Yes, the lower doses of Empagliflozin 5mg + Linagliptin 2.5mg with Metformin XR make it ideal for patients new to triple therapy.

Q2: Can the tablet be split if too large?
A2: No – it is extended-release; splitting or crushing will affect efficacy and safety.

Q3: Will I experience weight loss on this combination?
A3: Yes, modest weight loss (1–3 kg) is common due to Empagliflozin’s calorie-loss effect.

Q4: Does it still provide heart and kidney protection?
A4: Yes, even at 5mg Empagliflozin, clinical benefits for heart and kidneys are demonstrated.

Q5: Is hypoglycemia risk high with this triple combo?
A5: Risk remains low when used without insulin or sulfonylureas.

Empagliflozin, Linagliptin, Metformin Hydrochloride (Extended-Release), Microcrystalline Cellulose, Hypromellose, Crospovidone, Magnesium Stearate, Colloidal Anhydrous Silica, Film Coating

  • Contraindicated in type 1 diabetes and diabetic ketoacidosis
  • Risk of lactic acidosis (from metformin) – avoid in severe kidney impairment or excessive alcohol use
  • Stay hydrated to reduce dehydration risk from Empagliflozin
  • Monitor for genital mycotic infections or urinary tract infections
  • Long-term use may lower vitamin B12 levels – periodic monitoring advised
  • Store below 30°C and keep out of reach of children

You may also like

Recently viewed products